Vivre company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

vivre.com

Founded Year

1996

Stage

Series C | Alive

Total Raised

$26.6M

Last Raised

$8M | 22 yrs ago

About Vivre

Vivre is a company based in New York, New York. Vivre's investors include Rolaco Services, Charles River Ventures, RRE Ventures and North Bridge Venture Partners.

Vivre Headquarter Location

11 East 26th Street 15th Floor

New York, New York, 10010,

United States

212-739-6205

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Vivre News

Inaugural Fibroids Awareness Day aims to break the silence and isolation around misunderstood disease that will impact 70% of all women by age 50

Jul 21, 2022

Montreal, Quebec, CANADA MONTREAL, July 21, 2022 (GLOBE NEWSWIRE) -- Today, Vivre 100 Fibromes (Living Without Fibroids) officially declared July 21st as the first Fibroids Awareness Day in Canada – a date to increase understanding and shine a light on uterine fibroids, which impacts approximately 70% of all women by the age of 50 with many enduring symptoms and suffering in silence.i “Since I founded Vivre 100 Fibromes in 2016, my goal has been to build a community of support for women living with uterine fibroids to ensure they have proper access to resources and treatment options,” says Aïssatou Sidibé, President, Vivre 100 Fibromes. “When I was diagnosed in 2013, I waited too long to consult a specialist and experienced this condition alone – but my life improved significantly when I made lifestyle changes to manage my anemia and underwent successful surgery in 2018.” Uterine fibroids are non-cancerous tumors that can develop on the inside, outside and on the wall of the uterus.ii Symptoms of uterine fibroids can include heavier, prolonged, or painful periods, abdominal pain, anemia, pain during intercourse, frequent and unusual urges to urinate, infertility or miscarriage.iii Women of colour are more likely to be diagnosed with uterine fibroids, with 25% of Black women being diagnosed by the age of 25.iv   “My journey with the disease was quite intense and Vivre 100 Fibromes was like a family to me at a time when I truly hit a wall,” says Nydia Laplante, an entrepreneur and step fitness coach, who had a 16 cm-long fibroid removed through a delicate yet routine surgical procedure (myomectomy). It gave me hope and a support system where I had access to all these women with the same lived experience.” Thirty to 50% of women are carriers of fibroids, with symptoms that vary from woman to woman. In Canada alone, uterine fibroids account for 30% of hysterectomies, the second most common surgery for women after Cesarean section.v Early diagnosis and treatment are key in supporting women in managing uterine fibroids. “Women need to be more proactive and have open and honest conversations with their doctor or gynecologist about their reproductive health,” says Dr. Carole Kamga-Ngande, reproductive endocrinologist, department of obstetrics and gynecology, at the CHUM. “Over the last few years, we have made great technological advances to be able to detect fibroids and provide different treatment options based on the life stage of the patient.” In honour of Fibroids Awareness Day, Canadians are encouraged to share their stories using the hashtag #FightingFibroids and #Vivre100Fibromes. The Fibroids Awareness campaign was made possible through the support of AbbVie Canada. For more information and support visit: www.fibroidsandanemia.ca MEDIA ALERT: To mark Fibroids Awareness Day, Vivre 100 Fibromes is hosting an event at Terrasse Teranga in Montreal (185 Sherbrooke St. W) from 5:00 to 7:00 pm where our three spokespeople will be available for interviews. About Vivre 100 Fibromes: Founded in 2016, Vivre 100 Fibromes is a nonprofit organization whose mission is to improve the care of women with uterine fibroids. It does so by using a three-pronged approach: informing women, health professionals and all public institutions to bring the disease out of the shadows; supporting women to break their social isolation and offer them activities that promote their well-being; and contributing to researching and setting up medico-social partnerships between hospitals and health organizations. i Fibroids and Anemia. Accessed July 2022. ii Fibroids and Anemia. Accessed July 2022. iii Fibroids and Anemia. Accessed July 2022. iv Fibroids and Anemia. Accessed July 2022. v Fibroids and Anemia. Accessed July 2022. For additional information and media requests, please contact: Louis Payette

  • When was Vivre founded?

    Vivre was founded in 1996.

  • Where is Vivre's headquarters?

    Vivre's headquarters is located at 11 East 26th Street, New York.

  • What is Vivre's latest funding round?

    Vivre's latest funding round is Series C.

  • How much did Vivre raise?

    Vivre raised a total of $26.6M.

  • Who are the investors of Vivre?

    Investors of Vivre include North Bridge Venture Partners, RRE Ventures, CRV and Rolaco Services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.